Observational studyOncotarget2017

Combined evaluation of the FAS cell surface death receptor and CD8+ tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer.

Erik J Blok et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.